Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Star Imaging IPO
Price Band
₹135.0–142.0
Issue Size
₹69.47 Cr
Lot Size
1,000 shares
Min Investment
₹284,000
2 LOTS MIN
GMP
+₹5.0 (3.52%)
Issue Price
₹142.0
Subject to Sauda
₹3800
Paid only if allotted
Star Imaging IPO AI Summary
- Star Imaging IPO is listed on BSE SME in the Healthcare Service Provider sector.
- Price band: ₹135.0–₹142.0 per share, lot size 1,000 shares (min. investment ₹284,000, 2 lots minimum).
- Subscription window: 08 Aug–12 Aug 2025, listing on 18 Aug 2025.
- Current GMP is +₹5.0 (3.52%), an estimated listing price of ₹147 — unofficial and can change daily.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Star Imaging IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 12 Aug 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Star Imaging IPO Grey Market Premium (GMP) Today
GMP
+₹5.0
GMP %
+3.52%
Est. Listing
₹147.0
Updated: 25 Jul 2026 14:13
About the Company
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests. The company specializes in imaging services such as X-rays, ultrasounds, CT scans, MRIs, and laboratory tests, including blood tests, urine tests, and other specialized diagnostics. With advanced technology and experienced medical professionals, the company aims to offer accurate and timely reports to patients, helping healthcare providers in effective diagnosis and treatment. The company has a strong presence in multiple regions, offering services to both individuals and healthcare institutions. Services: Radiology: Digital X-ray, Mammography, CT scans, 4D & 5D ultrasound services. Pathology: Haematology, Microbiology, PCR (polymerase chain reaction), Histopathology Diagnotics: Routine Testing, Special Testing As of September 30th 2024, the company has 209 full time employees including executive directors. Competitive Strengths: Accurate Diagnosis Specialized Expertise Proper Sample Collection and Processing Procedures
Company Financials (₹ Cr)
As of 2025-03-31
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 98.16 | 81.64 | 61.23 |
| Total Income | 83.79 | 79.97 | 58.68 |
| Profit After Tax | 15.96 | 12.45 | 0.58 |
| EBITDA | 28.60 | 22.34 | 5.81 |
| NET Worth | 47.15 | 31.35 | 18.93 |
| Reserves and Surplus | 33.65 | 29.85 | 17.43 |
| Total Borrowing | 32.73 | 30.64 | 26.56 |
Key Ratios
EPS
₹11.82
NAV
₹34.93
ROE
40.65%
ROCE
29.92%
RoNW
40.65%
P/B Value
4.07
P/E Ratio
12.01
Market Cap
₹247.36 Cr
PAT Margin
19.10%
Debt/Equity
0.69
Promoters
Pawan Gupta and Chhaya Gupta
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 To Meet Working Capital Requirement 25.00 2 Repayment/prepayment of certain borrowings availed of by the Company 12.00 3 Funding the Capital Expenditure towards purchase of Refurbished Medical Equipment in running facilities 5.14 4 General Corporate Purposes 6.94 5 Issue Expenses 8.03 Total 57.11
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹58.68 Cr in the year ending 31 Mar 2023, increasing to ₹79.97 Cr by 31 Mar 2024, and further rising to ₹83.79 Cr in the year ending 31 Mar 2025.
Profit Trend
Profit after tax was ₹0.58 Cr for the year ending 31 Mar 2023, which grew to ₹12.45 Cr by 31 Mar 2024, and further increased to ₹15.96 Cr in the year ending 31 Mar 2025.
Valuation
The company's earnings per share (EPS) is ₹11.82, which gives it an implied P/E of 12.01 at the issue price. This is compared to its peers, which are trading at a P/E range of 12.01.
Grey Market Premium, Explained
The grey market premium (GMP) indicates the expected gain or loss on the listing day of an IPO. A positive GMP suggests that the shares may list at a higher price than the issue price, while a negative GMP indicates the opposite. GMP is determined by market demand and supply and can fluctuate leading up to the listing date.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their investment goals and risk tolerance. It is important to consider the company's fundamentals, market conditions, and potential for growth.
Who May Want to Wait
Investors with a low risk tolerance or those seeking guaranteed returns may want to avoid IPOs, as they can be subject to significant price fluctuations and uncertainties in the market.
IPO Timeline, Explained
The IPO opens for subscription on 8 August 2025 and closes on 12 August 2025, with allotment scheduled for 13 August 2025 and listing on 18 August 2025.
Listing Gains — The Risk
Listing-day gains can be unpredictable. While some IPOs may see a significant rise in share price on their first day of trading, others may not perform as well. Factors influencing listing gains include market sentiment, overall demand for the IPO, and the company's financial health.
This evaluation is generated from Star Imaging's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Star Imaging IPO GMP today?
Star Imaging IPO GMP today is +₹5.0 (3.52%), indicating an estimated listing price of ₹147. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Star Imaging IPO?
The price band of Star Imaging IPO is ₹135.0–₹142.0 per share.
When does Star Imaging IPO open and close?
Star Imaging IPO opens on 08 August 2025 and closes on 12 August 2025.
When does Star Imaging IPO list on the stock exchange?
Star Imaging IPO listed on 18 August 2025 at ₹147.0.
What is the lot size for Star Imaging IPO?
The lot size for Star Imaging IPO is 1000 shares, requiring a minimum investment of ₹284,000 (2 lots).
What is the price band for the IPO?
The price band for the IPO is ₹135.0 to ₹142.0.
What is the minimum investment required?
The minimum investment required is ₹284,000.
What is the lot size for the IPO?
The lot size for the IPO is 1,000 shares.
When is the IPO expected to be listed?
The IPO is expected to be listed on 18 August 2025.
What does GMP mean?
GMP stands for grey market premium, which indicates the expected price movement of the shares on the listing day.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
08 Aug 2025
Close
12 Aug 2025
Allotment
13 Aug 2025
Listing
18 Aug 2025
Similar IPOs in Healthcare Service Provider
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Star Imaging?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.